DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to 18 years

May 13, 2021

New Delhi [India], May 13 : The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat...

Mothers are at greater risk of developing clinical depression than their low-risk peers: Study

Apr 17, 2022

Pittsburgh (Pennsylvania) [US], April 17 : According to a new study, children of mothers with clinical depression are at three times greater risk to...

AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials from tomorrow onwards: Sources

Jun 14, 2021

New Delhi [India], June 14 : The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine,...

Subject Expert Committee gives nod to Covaxin for Phase 2, 3 trials on children aged 2 to 18 years

May 12, 2021

New Delhi [India], May 12 : The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3...

Clinical features, treatment received by children are inadequate to determine aetiology: DCGI replies to WHO

Oct 15, 2022

New Delhi [India], October 15 : Drugs Controller General of India (DCGI) on Saturday replied to World Health Organisation (WHO) and said as per...

AIIMS Delhi to start screening children for Covaxin trials from Monday

Jun 06, 2021

New Delhi [India], June 6 : The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigenous...